Coeptis Therapeutics Holdings, Inc. saw its share price fall by 40% following the announcement of its merger with Dogecoin miner Z Squared. This merger marks a significant strategic shift for the company, transitioning its focus from biotechnology to digital asset mining in the United States.

This dramatic change from biotechnology to Dogecoin mining has raised concerns about the company's strategic direction, leading to a swift and substantial negative market reaction.

Coeptis Acquires 9,000 Mining Rigs in Strategic Shift

The merger between Coeptis Therapeutics and Z Squared fundamentally alters Coeptis' business model, moving it from biotech into Dogecoin mining. This involves the acquisition of 9,000 U.S.-based mining rigs. Coeptis' biopharmaceutical operations will be spun off as a separate entity. The combined company will rebrand as Z Squared, Inc., with David Halabu, CEO of Z Squared, leading the operation.

David Halabu, CEO, Z Squared, stated, "We are excited to take this step towards our goal of creating the largest publicly-traded company in the United States primarily focused on DOGE mining. We’re proud of our strategy to bring retail and institutional audiences alike in the public markets a focused exposure to a DOGE asset that currently has over $20B in market capitalization. We believe we have assembled a stellar team that has the requisite expertise and infrastructure." - The Block

Coeptis Shares Drop 40% Amid Market Skepticism

The nearly 40% drop in Coeptis' share price following the announcement reflects significant market skepticism. This substantial decline highlights investor concerns about the strategic shift and the inherent volatility of the cryptocurrency mining sector.

Future success depends heavily on regulatory approvals and investor sentiment. Past mergers involving similar shifts into cryptocurrency mining have often resulted in volatile stock performance. Market capitalization fluctuations and the valuation of mining equipment add further complexity to the financial picture.

Expert Doubts on Post-Merger Dogecoin Impact

Historical precedents exist of non-crypto companies entering the mining sector, often experiencing sharp stock price declines after merger announcements. This suggests an unpredictable market response, mirroring the often-uncertain results of biotech firms' previous forays into cryptocurrency.

Experts suggest that without a significant surge in Dogecoin's price, the stock may struggle due to execution risks. The overall cryptocurrency market sentiment, rather than individual mining efforts, is likely to be the primary driver of DOGE price movements.

Disclaimer: This information is for general knowledge only and does not constitute financial advice. Cryptocurrency investments are inherently risky. We do not guarantee the accuracy of this information and are not liable for any losses incurred. Always conduct thorough research before making any investment decisions.

Read original article on kanalcoin.com